Video

Kenneth Warrington, MD: Identifying ANCA-Associated Vasculitis

Author(s):

ANCA-associated vasculitis may present like sinusitis, but it typically affects multiple organ systems.

As part of HCPLive’s® State of the Science series, Kenneth Warrington, MD, Chair, Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, led a discussion about the burden of ANCA-associated vasculitis with Tanaz Kermani, MD, MS, Division of Rheumatology, UCLA, and Matthew Koster, MD, Mayo Clinic Rheumatology.

In this interview, Warrington shared the motivation that led him to this field. He also differentiated how to identify a case of ANCA-associated vasculitis compared with a common condition like sinusiti, with the main difference being symptom persistence.

"So, one of the hallmarks of vasculitis is that patients might have sinus inflammation, lung inflammation, kidney inflammation, skin inflammation, joint inflammation, all going on at the same time," Warrington explained.

Basic laboratory studies of inflammation markers would also indicate high markers of inflammation in patients with vasculitis. Warrington said this is a sign that providers should refer to a specialist.

"If the patient has multiple organ systems that are being affected concurrently," he said, "that should clue them in that vasculitis might be something to think about."

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
© 2024 MJH Life Sciences

All rights reserved.